1-6 of 6
Steven Lane
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Asciminib monotherapy as frontline treatment of chronic-phase chronic myeloid leukemia: results from the ASCEND study

Clinical Trials & Observations
David T. Yeung, Naranie Shanmuganathan, John Reynolds, Susan Branford, Mannu Walia, Agnes S. M. Yong, Jake Shortt, Lynette Chee, Nicholas Viiala, Ilona Cunningham, David M. Ross, Alwyn D’Souza, Matthew Wright, Rosemary Harrup, Cecily Forsyth, Robin Filshie, Steven Lane, Peter Browett, Carolyn Grove, Andrew P. Grigg, Timothy P. Hughes
Journal: Blood
Blood (2024) 144 (19): 1993–2001.
https://doi.org/10.1182/blood.2024024657
Published: 2024
Includes: Supplemental data
Journal Articles

Real-world experience with caplacizumab in the management of acute TTP

Clinical Trials & Observations
Tina Dutt, Rebecca J. Shaw, Matthew Stubbs, Jun Yong, Benjamin Bailiff, Tanya Cranfield, Maeve P. Crowley, Michael Desborough, Toby A. Eyre, Richard Gooding, John Grainger, John Hanley, Joanna Haughton, Joannes Hermans, Quentin Hill, Louise Humphrey, Gillian Lowe, Hamish Lyall, Muhammad Mohsin, Phillip L. R. Nicolson, Nicole Priddee, Alexandros Rampotas, Rachel Rayment, Susan Rhodes, Alice Taylor, William Thomas, Oliver Tomkins, Joost J. Van Veen, Steven Lane, Cheng-Hock Toh, Marie Scully
Journal: Blood
Blood (2021) 137 (13): 1731–1740.
https://doi.org/10.1182/blood.2020007599
Published: 2021
Includes: Supplemental data
Journal Articles

A Novel Assay of Neutrophil Extracellular Traps (NETs) Formation Independently Predicts DIC and Identifies the Rationale for Anti-IL-8 Therapies

Simon Timothy Abrams, PhD BSc, Ben Morton, MBChB, MD, Yasir Alhamdi, MBChB, PhD, Mohmad Alsabani, Zhenxing Cheng, Steven Lane, PhD, Ingeborg Welters, PhD, Guozheng Wang, MD PhD, Cheng-Hock Toh, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 440.
https://doi.org/10.1182/blood-2019-128493
Published: 2019
Journal Articles

WT1 Expression Levels at Diagnosis and as a Marker of Minimal Residual Disease (MRD) in Patients with Acute Myeloid Leukaemia (AML).

James X Gray, MD, PhD, Lyle McMillen, PhD, Russell Saal, MMedSc, Steven Lane, MBBS, Peter Mollee, MBBS, Robert Bird, MBBS, Devinder Gill, MBChB, Paula Marlton, MBBS
Journal: Blood
Blood (2009) 114 (22): 2639.
https://doi.org/10.1182/blood.V114.22.2639.2639
Published: 2009
Journal Articles

Prolonged Hematologic Toxicity from the Hyper-CVAD Regimen; Manifestations, Frequency, and Natural History in a Cohort of 125 Consecutive Patients.

Saar Gill, MBBS, Steven Lane, MBBS, Julie Crawford, MBBS, Peter Mollee, MBBS, Paula Marlton, MBBS, Gavin Cull, MBBS, Miles Prince, MBBS, MD, John Francis Seymour, MBBS, PhD
Journal: Blood
Blood (2006) 108 (11): 2441.
https://doi.org/10.1182/blood.V108.11.2441.2441
Published: 2006
Journal Articles

Clinical and Functional Evidence That Drug Transporter Expression Dictates the Response to Imatinib in Chronic Myeloid Leukaemia.

Lihui Wang, MD, Athina Giannoudis, PhD, Steven Lane, PhD, Paula R. Williamson, PhD, Munir Pirmohamed, PhD, Richard E. Clark, MD
Journal: Blood
Blood (2006) 108 (11): 2145.
https://doi.org/10.1182/blood.V108.11.2145.2145
Published: 2006